<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02653950</url>
  </required_header>
  <id_info>
    <org_study_id>0576-15-RMB</org_study_id>
    <nct_id>NCT02653950</nct_id>
  </id_info>
  <brief_title>Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum</brief_title>
  <official_title>Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <brief_summary>
    <textblock>
      In this study the investigators aim to assess whether endoscopic septoplasty is effective at&#xD;
      improving patients QOL and reducing postoperative signs and complications.&#xD;
&#xD;
      Primary outcome: To assess the differences in overall QOL between endoscopic and traditional&#xD;
      septoplasty after adjusting for pertinent confounding variables.&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
        1. To evaluate the post-operative complication rate in patients undergoing endoscopic&#xD;
           septoplasty compared to traditional.&#xD;
&#xD;
        2. To evaluate the differences in the operation time between the two different approaches.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nasal obstruction is one of the most common complaints that the otorhinolaryngologist faces&#xD;
      in the daily practice. Deviated nasal septum (DNS) is a very frequently encountered and&#xD;
      common cause. It not only causes breathing difficulties but also results in improper aeration&#xD;
      of paranasal sinuses predisiposing to sinusitis and also results in drying of mucosa leading&#xD;
      to crusting and epistaxis 1,2. DNS can also be accompanied with hypertrophic nasal turbinates&#xD;
      causing sleep disturbances and snoring3.&#xD;
&#xD;
      Septoplasty is an accepted and common surgical intervention to improve the nasal airway4 and&#xD;
      sleep disturbances3.&#xD;
&#xD;
      Traditional septoplasty procedure involves sum mucosal resection of the anterior septum. The&#xD;
      results for long-term symptom relief after traditional septoplasty are contradictory in&#xD;
      reviewed publications 5.&#xD;
&#xD;
      In the last two decades the endoscopic Sino nasal surgery has been widely used including&#xD;
      endoscopic approach for septoplasty. Endoscopic septoplasty as a minimally invasive technique&#xD;
      where the dissection of the nasal septal flap can be limited minimizing trauma. The excellent&#xD;
      visualization is presumed to decrease morbidity and post-operative swelling in isolated&#xD;
      septal deviation by limiting the excision to the area of deviation 2. Furthermore, diagnosing&#xD;
      and treating abnormalities of the lateral wall of the nose at the same sitting is only&#xD;
      feasible in the endoscopic approach.&#xD;
&#xD;
      At the time of this study, there are no studies comparing the changes of quality of life in&#xD;
      patients undergoing traditional septoplasty Vs endoscopic septoplasty.&#xD;
&#xD;
      The investigators aimed to assess whether endoscopic septoplasty is effective at improving&#xD;
      patients QOL and reducing postoperative signs and complications.&#xD;
&#xD;
      Aims&#xD;
&#xD;
      Primary:&#xD;
&#xD;
      1) To assess the differences in overall QOL between endoscopic and traditional septoplasty&#xD;
      after adjusting for pertinent confounding variables.&#xD;
&#xD;
      Secondary:&#xD;
&#xD;
        1. To evaluate the post-operative complication rate in patients undergoing endoscopic&#xD;
           septoplasty compared to traditional.&#xD;
&#xD;
        2. To evaluate the differences in the operation time between the two different approaches.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Quality of life</measure>
    <time_frame>Baseline (maximum 3 months before surgery), at 2-3 weeks, and 3-4 months after the surgery.</time_frame>
    <description>quality of life will assessed using Sino-Nasal Outcome Test-22 (SNOT-22) scores.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Intranasal Surgery</condition>
  <arm_group>
    <arm_group_label>Traditional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a control arm of patients undergoing traditional septoplasty for DNS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing endoscopic septoplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic septoplasty</intervention_name>
    <description>Endoscopic surgery; septoplasty with or without middle turbenectomy</description>
    <arm_group_label>Endoscopic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional septoplasty</intervention_name>
    <description>septoplasty under direct vision</description>
    <arm_group_label>Traditional</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of nasal obstruction and deviated nasal septum with or without hypertrophy&#xD;
             of nasal turbinates.&#xD;
&#xD;
          2. Patient undergoing surgery for repairing the deviated nasal septum.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of bilateral acute or chronic rhinosinusitis or nasal polyposis&#xD;
&#xD;
          2. Patients undergoing endoscopic sinonasal surgery.&#xD;
&#xD;
          3. Diagnosed with inflammatory (e.g. Wegener's granulomatosis, sarcoidosis) or neoplastic&#xD;
             nasal pathology&#xD;
&#xD;
          4. Diagnosed with systemic conditions affecting the nose e.g. Cystic fibrosis,&#xD;
             Kartagener's syndrome&#xD;
&#xD;
          5. Patients listed for revision surgery&#xD;
&#xD;
          6. Neoplasms - untreated or under active or recent treatment with chemotherapy or&#xD;
             radiotherapy&#xD;
&#xD;
          7. Unable to give informed consent due to mental impairment&#xD;
&#xD;
          8. Unable to adhere follow up or treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shorook Na'ara, MD</last_name>
    <phone>00972507977510</phone>
    <email>shorook.n@gmail.com</email>
  </overall_contact>
  <verification_date>January 2016</verification_date>
  <study_first_submitted>January 6, 2016</study_first_submitted>
  <study_first_submitted_qc>January 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2016</study_first_posted>
  <last_update_submitted>January 10, 2016</last_update_submitted>
  <last_update_submitted_qc>January 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>SHOROOK NA'ARA MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

